Hodgkin Lymphoma in a Case of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors
Chronic myeloid leukemia (CML) is characterized by increased and unregulated proliferation of granulocytic lineage in the bone marrow and presence of these immature myeloid cells in the peripheral blood with presence of Philadelphia (Ph) chromosome. Tyrosine kinase inhibitors are the most important...
Main Authors: | Smeeta GAJENDRA, Archana SHARMA, Rashi SHARMA, Sunil Kumar GUPTA, Nitin SOOD, Ritesh SACHDEV |
---|---|
Format: | Article |
Language: | English |
Published: |
Federation of Turkish Pathology Societies
2019-01-01
|
Series: | Türk Patoloji Dergisi |
Subjects: | |
Online Access: |
http://www.turkjpath.org/pdf.php3?id=1805
|
Similar Items
-
Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia
by: N N Sharkunov, et al.
Published: (2012-11-01) -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01) -
Synchronous Diffuse Large B-Cell Lymphoma and Malignant Clonal Plasma Cells in Bone Marrow As Primary Presentation: A Diagnostic and Therapeutic Challenge
by: Ritesh Sachdev, et al.
Published: (2015-04-01) -
Hodgkin Lymphoma as a Secondary Neoplasm During Therapy for Chronic Myeloid Leukaemia: Case Report and Review of the Literature
by: Paczkowska E, et al.
Published: (2021-04-01) -
Chronic myeloid leukemia and ferritin levels
by: Kumar Saurabh, et al.
Published: (2017-01-01)